115 related articles for article (PubMed ID: 2590613)
1. Factors affecting free (unbound) lignocaine concentration in suspected acute myocardial infarction.
Routledge PA; Stargel WW; Barchowsky A; Wagner GS; Shand DG
Br J Clin Pharmacol; 1989 Nov; 28(5):593-7. PubMed ID: 2590613
[TBL] [Abstract][Full Text] [Related]
2. Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failure.
Prescott LF; Adjepon-Yamoah KK; Talbot RG
Br Med J; 1976 Apr; 1(6015):939-41. PubMed ID: 1268491
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.
Nattel S; Gagne G; Pineau M
Clin Pharmacokinet; 1987 Nov; 13(5):293-316. PubMed ID: 2891461
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of lignocaine.
Benowitz NL; Meister W
Clin Pharmacokinet; 1978; 3(3):177-201. PubMed ID: 350470
[TBL] [Abstract][Full Text] [Related]
5. The appropriate dosage regime for the transition from intravenous lignocaine to oral tocainide after acute myocardial infarction.
Upward JW; Holt D; Emery P; Akhras F; Jackson G
Eur J Clin Pharmacol; 1983; 25(5):589-94. PubMed ID: 6420162
[TBL] [Abstract][Full Text] [Related]
6. Relation between plasma lignocaine levels and induced haemodynamic changes.
Binnion PF; Murtagh G; Pollock AM; Fletcher E
Br Med J; 1969 Aug; 3(5667):390-2. PubMed ID: 5797780
[TBL] [Abstract][Full Text] [Related]
7. Age-dependent lidocaine disposition in patients with acute myocardial infarction.
Cusson J; Nattel S; Matthews C; Talajic M; Lawand S
Clin Pharmacol Ther; 1985 Apr; 37(4):381-6. PubMed ID: 3978999
[TBL] [Abstract][Full Text] [Related]
8. A free lignocaine index as a guide to unbound drug concentration.
Routledge PA; Lazar JD; Barchowsky A; Stargel WW; Wagner GS; Shand DG
Br J Clin Pharmacol; 1985 Dec; 20(6):695-8. PubMed ID: 4092000
[TBL] [Abstract][Full Text] [Related]
9. On the role of alpha 1-acid glycoprotein in lignocaine accumulation following myocardial infarction.
Barchowsky A; Shand DG; Stargel WW; Wagner GS; Routledge PA
Br J Clin Pharmacol; 1982 Mar; 13(3):411-5. PubMed ID: 7059443
[TBL] [Abstract][Full Text] [Related]
10. Logical approach to lignocaine therapy.
Aps C; Bell JA; Jenkins BS; Poole-Wilson PA; Reynolds F
Br Med J; 1976 Jan; 1(6000):13-5. PubMed ID: 1247716
[TBL] [Abstract][Full Text] [Related]
11. Comparative haemodynamic effects of intravenous lignocaine, disopyramide and flecainide in uncomplicated acute myocardial infarction.
Silke B; Frais MA; Verma SP; Reynolds GW; Hafizullah M; Kalra PA; Jackson NC; Taylor SH
Br J Clin Pharmacol; 1986 Dec; 22(6):707-14. PubMed ID: 3105568
[TBL] [Abstract][Full Text] [Related]
12. Blood levels of lignocaine after intramuscular administration to patients with proven or suspected acute myocardial infarction.
Rydén L; Wasir H; Conradsson TB; Olsson B
Br Heart J; 1972 Oct; 34(10):1012-7. PubMed ID: 5086967
[No Abstract] [Full Text] [Related]
13. Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
Bax ND; Tucker GT; Woods HF
Br J Clin Pharmacol; 1980 Oct; 10(4):353-61. PubMed ID: 7448106
[TBL] [Abstract][Full Text] [Related]
14. Observations on intravenous administration of lignocaine in patients with myocardial infarction.
Campbell NP; Kelly JG; Adgey AA; McDevitt DG; Pantridge JF
Br Heart J; 1978 Dec; 40(12):1371-5. PubMed ID: 737094
[TBL] [Abstract][Full Text] [Related]
15. Tolerability and antiarrhythmic efficacy of disopyramide compared to lignocaine in selected patients with suspected acute myocardial infarction.
Rønnevik PK; Gundersen T; Abrahamsen AM
Eur Heart J; 1987 Jan; 8(1):19-24. PubMed ID: 2880718
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic action of lignocaine in early myocardial infarction. Plasma levels after combined intramuscular and intravenous administration.
Sheridan DJ; Crawford L; Rawlins MD; Julian DG
Lancet; 1977 Apr; 1(8016):824-5. PubMed ID: 67335
[TBL] [Abstract][Full Text] [Related]
17. Simple lignocaine regimen for transit to hospital after myocardial infarction.
Barber JM; Boyle DM; Hussain Z; McDevitt DG
Br Heart J; 1977 Dec; 39(12):1361-3. PubMed ID: 603738
[TBL] [Abstract][Full Text] [Related]
18. Changes in lignocaine disposition during long-term infusion in patients with acute ventricular arrhythmias.
Thomson AH; Kelman AW; de Vane PJ; Hillis WS; Whiting B
Ther Drug Monit; 1987 Sep; 9(3):283-91. PubMed ID: 3672571
[TBL] [Abstract][Full Text] [Related]
19. [Lidocaine elimination and dose adjustment in acute heart infarct and heart insufficiency].
Kettner W; Banditt P; Walther H
Z Gesamte Inn Med; 1984 Jul; 39(14):335-42. PubMed ID: 6485432
[TBL] [Abstract][Full Text] [Related]
20. Lignocaine disposition in blood in epilepsy.
Routledge PA; Stargel WW; Finn AL; Barchowsky A; Shand DG
Br J Clin Pharmacol; 1981 Nov; 12(5):663-6. PubMed ID: 7332731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
